Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 July 2022 | Story Andre Damons | Photo Supplied
Prof Martie Smith and Prof Drik Opperman
Prof Martie Smit and Prof Dirk Opperman in the Department of Microbiology and Biochemistry filed a patent entitled “Process for the chemical modification of alkanes, fatty acids and fatty alcohols”.

Flavours and fragrances have a wide application in the food, feed, cosmetic, chemical and pharmaceutical sectors. Many flavour compounds are still produced via chemical synthesis or via extraction from plant or animal sources. However, there is increasing interest in their bio-production or the use of flavour compounds of (micro) biological origin. 

One reason for this shift is that chemical synthesis often uses environmentally unfriendly processes. Chemical synthesis usually also produces racemic mixtures with the second enantiomer, mirror image of the looked-for compound, often having undesirable organoleptic properties. Furthermore, the consumer has developed a “chemophobia”-attitude towards synthetic chemical compounds, especially when related to food and home-care products.  This applies even to nature-identical compounds – products that occur in nature but are produced via a non-natural chemical process. Products produced with the use of enzymes or microbes from “natural” substrates can be labelled “natural”. The flavour and fragrance industry thus pay higher prices for such products labelled as “natural”.  

The invention

A University of the Free State (UFS) team, led by Prof Martie Smit and Prof Dirk Opperman in the Department of Microbiology and Biochemistry are conducting exciting research in this area. They filed a patent entitled “Process for the chemical modification of alkanes, fatty acids and fatty alcohols”.  

The invention relates to a process for the enzymatic in-chain hydroxylation of C12 to C16 fatty acids, alcohols, and alkanes. Hydroxylation of C12 fatty acid and alcohol provides routes for the synthesis of “natural” δ-dodecalactone. The advantage of these routes is that they do not rely on massoia lactones. Massoia lactones are derived from the bark of Massoia trees which grow in Indonesia. Harvesting of the bark kills the trees.  

The cytochrome P450 enzymes (P450s) claimed in this patent are to the inventors’ knowledge the most regioselective enzymes described thus far that can be used for the synthesis of δ-dodecalactone from lauric acid or 1-dodecanol. The approach that the technology takes is to claim cytochrome P450 enzymes that share 70 % amino acid identity to a set of selected P450s for the regioselective hydroxylation of lauric acid and 1-dodecanol to synthesise δ-dodecalactone.

Still in early stage

The current state of development is early stage with the technology only demonstrated in the laboratory on a small scale (100-200 ml). Before the technology can be commercialised the team would need to further improve the regioselectivity and stability of the P450s and proof that the reactions can be scaled up in bioreactors. The technology will probably be delivered as an enzyme (amino acid sequence) with the desired properties. 

There are other research groups working on a synthetic biology approach for the de novo synthesis of δ-dodecalactone from glucose by genetically engineered microbes. It is still unclear how such a process will compare in terms of product yields, economics and environmental impact with the processes proposed by the UFS patent.

If the team had to partner with a commercial company, their first choice would be to work with an established flavour and fragrance company. Another possibility would be the small French flavour and fragrance company that Dr Alizé Pennec, the post-doc and co-inventor who initially discovered the unique P450 activity, is working for.

Please view the videos for more information on patents.

The Vice-Rector: Research and Internationalisation has released two new calls for applications for funding. Academic staff and researchers are encouraged to submit applications for these funds. At this stage we are not accepting projects from Research Fellows. 

The two funds are: 

1.  The Industrial Engagement Fund 
2.  The Intellectual Property Commercialisation Fund

Each fund has its own guidelines and application process. The guidelines are attached. The applications must be filled in on RIMS.

The RIMS application forms can be found through this link

For more information please click the documents below:



News Archive

Three more Kovsie staff members involved in Olympic Games
2012-05-30

 

Dr Derik Coetzee
Photo: Supplied
30 May 2012

The South African men’s hockey team will practice on our Bloemfontein Campus from 28 May to 8 June 2012, and the team count on the assistance of three Kovsies to prepare them for the Olympic Games taking place in London later this year.  

Dr Derik Coetzee, senior lecturer in the Department of Exercise and Sport Science and Head of our High Performance Centre, has been appointed conditioning coach of the team. He will be assisted by Colleen Jones and Riaan Schoeman, also from this department.

The UFS team and Mr Gregg Clark, the team’s coach, will work out a periodisation programme for the team, which will continue until the hockey finals at the Olympic Games. The programme includes the correct exercises, volume, intensity and number of exercise sessions per week.

This is not the first time that Dr Coetzee has assisted sports teams to prepare for important events. In 2007, he was the conditioning coach of the Springbok rugby team that won the World Cup in France. He was also the conditioning coach of the under-21 Springbok team in 2002 that won the Junior World Cup Tournament. 

Dr Coetzee says it is a challenge to ensure that the team performs well at the Olympic Games. “The joy on the faces of the coach and players when they qualified in Japan cannot be described because many people thought they would not qualify.”

With the addition of Dr Coetzee, Ms Jones and Mr Schoeman, a total of six staff members from the UFS will be involved with the Olympic Games and the Paralympic Games. The other three are:

  • Dr Louis Holtzhausen, Head of the university’s Department of Sports and Exercise Medicine, has been selected as team doctor for the more than 300 athletes that will represent South Africa at this year’s Olympic Games (in London).
  • Ms Ebeth Grobbelaar, Assistant Director of the South African Testing Laboratory for Prohibited Substances at the UFS, was invited to be involved in the Drugs Control Centre in the unit against prohibited substances which will test sportsmen and -women during the games.
  • Ms Hetsie Veitch, Head of the Unit for Students with Disabilities, has been invited to be a member of the Classification Panel at the final USA Paralympic athletics trials.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept